BioHarvest Sciences Inc.
BHST
$1.95
$0.042.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.78% | 8.23% | 24.57% | 38.66% | 41.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.78% | 8.23% | 24.57% | 38.66% | 41.28% |
| Cost of Revenue | 9.51% | 6.28% | 21.74% | 23.79% | 17.23% |
| Gross Profit | -0.08% | 9.62% | 26.73% | 49.97% | 63.96% |
| SG&A Expenses | 6.49% | 8.05% | 14.39% | 11.46% | 46.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.82% | 7.95% | 13.63% | 15.58% | 32.38% |
| Operating Income | -38.13% | -6.69% | 33.55% | 56.23% | -2.20% |
| Income Before Tax | 9.35% | -12.83% | 23.07% | 8.89% | -488.21% |
| Income Tax Expenses | 33.33% | 21.05% | -900.00% | -- | -- |
| Earnings from Continuing Operations | 8.95% | -12.96% | 25.44% | 6.55% | -493.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.95% | -12.96% | 25.44% | 6.55% | -493.89% |
| EBIT | -38.13% | -6.69% | 33.55% | 56.23% | -2.20% |
| EBITDA | -43.11% | -6.52% | 36.16% | 69.45% | 0.78% |
| EPS Basic | 30.40% | 13.64% | 39.53% | 7.03% | -460.71% |
| Normalized Basic EPS | 30.73% | 13.73% | 37.63% | 9.29% | -454.37% |
| EPS Diluted | 30.40% | 13.64% | 39.53% | 7.03% | -460.71% |
| Normalized Diluted EPS | 30.73% | 13.73% | 37.63% | 9.29% | -454.37% |
| Average Basic Shares Outstanding | 30.81% | 30.82% | 23.33% | 0.48% | 5.99% |
| Average Diluted Shares Outstanding | 30.81% | 30.82% | 23.33% | 0.48% | 5.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |